Kearner Turner

Kearney Turner is a Saint Paul, Minnesota–based healthcare executive who has spent his career building and scaling value-based care companies. He holds a Bachelor's degree in Psychology from Amherst College.

Turner is best known as an early operator at Strive Health, a value-based kidney-care company, where he was one of the first five employees, joining in December 2019. Working alongside the founding team, he helped define the business model and go-to-market strategy, and progressed through roles including Strategy & Development Manager, Director and Senior Director of Market Development, and ultimately Vice President of Growth. In that capacity he led business development with payors and risk-based providers. Strive Health went on to raise substantial venture capital — including a $166M round in 2023 backed by CVS Health Ventures, New Enterprise Associates, and others — and is regarded as a leading name in value-based nephrology.

He currently serves as Senior Vice President / Head of Growth at Crosswalk Health, a company transforming pre-hospital and 911-based care by partnering with first-responder agencies, community providers, and payors to deliver "needs-matched," cost-effective care to patients who primarily access the healthcare system via emergency services. Crosswalk is co-founded and led by CEO Jonathan (Jon) Collins; Turner is a member of the leadership team, not a founder.

His stated professional expertise is in value-based contracting between payors and providers, and in building and scaling risk-based partnerships — the through-line across both Strive Health and Crosswalk Health.

• Stage: Seed-stage / early angel checks (per the supplied designation).
• Sector alignment: His operating credibility is in value-based healthcare, kidney/renal care, pre-hospital and emergency (911) care, and payor–provider risk arrangements — the areas where he would bring the most differentiated diligence and network value.
• Operator-angel profile: As an early employee (#5) at a company that scaled to unicorn-adjacent funding, he fits the "operator angel" pattern — value beyond capital in the form of go-to-market strategy, payor contracting know-how, and provider relationships.
• *No publicly stated personal investment thesis or check-size figures were found; do not represent specific numbers as confirmed.*